Evaluating Patient Risk Factors for Moderate Sedation

Wednesday, February 11, 2026
5:00 pm PST / 8:00 pm EST

Gain the knowledge for safer sedation and patient care.

Most people have some degree of anxiety about going to the dentist, possibly keeping them from receiving basic oral care that can prevent significant dental disease. Oral and moderate intravenous sedation can be used to reduce those fears and allow patients to receive the care they need. However, many of these people come with a list of medical conditions and medications that can make treatment more challenging.

Join Dr. Jay Reznick and DOCS Education for Evaluating Patient Risk Factors for Moderate Sedation, a new program that will provide the basics of the most clinically relevant medical disorders and medications you’ll encounter in daily practice. Moderate parenteral sedation has a wide margin of safety when used appropriately by well-trained clinicians. The ability to evaluate a patient’s health prior to initiating any type of sedation is an essential skill for all dentists.

Learning Objectives:

• Understand the fundamentals of everyday cardiopulmonary disease that may present in patients who desire sedation.
• Identify the various types of medications used to treat heart disease, hypertension, and heart failure.
• Determine whether oral or moderate intravenous sedation would be most appropriate to use for each patient.
• Learn to physically evaluate each patient to establish the best approach to safe dental care.
• Correctly assign a physical status risk category in alignment with the American Society of Anesthesiologists’ classification.
• Understand how to modify the sedation treatment plan for patients in different special risk categories.

This webinar is free to attend. We offer 1 CE for DOCS Members and Trial Members who attend the live presentation.

If you are not yet a Member but would like to earn the 1 CE for attending, as well as experience the many benefits of DOCS Membership, consider joining as a Trial Member for only $1.* There is no obligation or risk; cancel anytime.

About the Presenter(s):

Jay B. Reznick, DMD, MD, is a highly respected, board-certified oral and maxillofacial surgeon with over two decades of clinical, academic, and technological leadership in the field. A Diplomate of the American Board of Oral and Maxillofacial Surgery, Dr. Reznick is known for his innovative approach to surgical care and his commitment to advancing the profession through education and technology. He earned his undergraduate degree in Biology from the University of California, Berkeley, his Doctor of Dental Medicine (DMD) from Tufts University, and his Doctor of Medicine (MD) from the University of Southern California.

A prolific author and frequent lecturer at national and international conferences, Dr. Reznick serves as a consultant and advisory board member for several dental and surgical product manufacturers and journals. He directed the Southern California Center for Oral and Facial Surgery in Tarzana, California, for 25 years before joining Sage Dental, where he continues to bring his expertise and passion to patient care.

 

*Trial Membership Offer is open to dentists who have not participated in the Trial Membership program within the past two (2) years. After 60 days, if not cancelled, the Trial Membership will upgrade to a Standard Membership at $59.95/mo for a one-year commitment. Refer to terms of service for details.

 

---

DOCS Education is designated as an Approved PACE Program Provider by the Academy of General Dentistry. The formal continuing education programs of this program provider are accepted by the AGD for Fellowship/Mastership and membership maintenance credit. Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement. The current term of approval extends from 09/17/2000 to 12/31/2026. Provider ID# 217651.